Calendar Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 20/06/2025 BST			5-day change	1st Jan Change
4.510 ^USD	-0.44%		0.00%	-5.85%

06-12	Vanda Pharmaceuticals Inc., Q1 2025 Earnings Call, May 07, 2025
06-10	Vanda Pharmaceuticals Inc. Announces First Patient Dosed in A Trial Evaluating VCA-894A in Charcot-Marie-Tooth Disease Type 2S	CI

Chart calendar Vanda Pharmaceuticals Inc.

98d5b2d11c1b22.zUm4cT57Jom4iPMeDgC-loLoFxGiuNN0gUxnKd3BBwQ.hx_JEFU4HsLSvMVaYWLWx_Tbc3r94LZD0i0odruka0z4IYhDDipr7vHNvg~2ffe898de3074d8bfe2a5ad277151dbd

Upcoming events on Vanda Pharmaceuticals Inc.

23/07/2025	Q2 2025 Earnings Release (Projected)
28/10/2025	Q3 2025 Earnings Release (Projected)
10/02/2026	Q4 2025 Earnings Release (Projected)
12/05/2026	Q1 2026 Earnings Release (Projected)

Past events on Vanda Pharmaceuticals Inc.

05/06/2025 14:00	Annual General Meeting
26/05/2025	American Society of Clinical Psychopharmacology Meeting - Poster Number: T19
20/05/2025	Mizuho Neuro & Ophthalmology Summit
07/05/2025 21:30	Q1 2025 Earnings Call
07/05/2025 21:01	Q1 2025 Earnings Release
08/04/2025	American Academy of Neurology Meeting - Poster Number: 11-017
13/02/2025 21:30	Q4 2024 Earnings Call
13/02/2025 21:01	Q4 2024 Earnings Release
21/11/2024 11:30	Jefferies London Healthcare Conference
19/11/2024 14:45	Stifel Healthcare Conference
06/11/2024 21:30	Q3 2024 Earnings Call
06/11/2024 21:02	Q3 2024 Earnings Release
19/09/2024 13:00	Cantor Global Healthcare Conference
10/09/2024 19:00	H.C. Wainwright Global Investment Conference
06/09/2024 16:00	Wells Fargo Healthcare Conference
31/07/2024 21:30	Q2 2024 Earnings Call
31/07/2024 21:01	Q2 2024 Earnings Release
06/06/2024 19:00	Jefferies Global Healthcare Conference
17/05/2024 14:00	Annual General Meeting
08/05/2024 21:30	Q1 2024 Earnings Call

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	254 258 -1.21%	193 184 4.47%	199 199 -0.34%	228	318	367
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	6,33 5,50 15.07%	-14,0 -18,4 24.17%	-40,7 -38,4 -5.99%	-114	-40,2	-14,8
Earnings before Tax (EBT) Million USD	Released Forecast Spread	11,3 6,20 82.26%	6,34 2,60 143.81%	-22,9 -21,8 -5.38%	-97,0	-21,3	-2,00
Net income Million USD	Released Forecast Spread	6,28 2,70 132.41%	2,51 -0,50 601.8%	-18,9 -18,7 -0.96%	-88,1	-22,7	-2,00
EPS USD	Released Forecast Spread	0,11 0,04 175%	0,04 -0,01 500%	-0,33 -0,32 -3.13%	-1,49	-0,39	-0,03
Announcement Date		08/02/23	07/02/24	13/02/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	38,8 44,5 -12.78%	45,3 37,0 22.35%		50,5 47,9 5.46%	47,7 49,2 -3.06%	53,2 52,3 1.79%	50,0 45,1 10.87%	54,8	58,8	64,1	67,6	75,3	83,5	91,9
EBIT Million USD	Released Forecast Spread	-6,00 -2,60 -130.58%	-7,09 -11,5 38.31%		-10,1 -17,0 40.36%	-11,0 -14,8 25.44%	-10,3 -10,4 0.94%	-41,0 -42,0 2.35%	-25,3	-25,5	-22,7	-21,1	-15,1	-9,23	-2,48
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-0,12 -2,60 95.38%	-1,66 -5,40 69.24%		-5,52 -12,4 55.41%	-6,24 -10,2 38.83%	-6,50 -6,94 6.37%	-37,4 -35,3 -5.82%	-21,5	-20,2	-17,9	-17,6	-11,7	-5,97	0,76
Net income Million USD	Released Forecast Spread	0,14 -2,60 105.27%	-2,40 -5,40 55.56%	-4,15	-4,52 -12,4 63.48%	-5,32 -9,54 44.21%	-4,91 -6,33 22.43%	-29,5 -35,0 15.84%	-21,1	-19,9	-17,6	-17,6	-11,7	-6,08	0,38
EPS USD	Released Forecast Spread	0,00 -0,04 -	-0,04 -0,09 55.56%	-0,07	-0,08 -0,21 61.9%	-0,09 -0,16 44.9%	-0,08 -0,11 27.27%	-0,50 -0,60 16.2%	-0,36	-0,34	-0,30	-0,25	-0,13	-0,05	0,04
Announcement Date		08/11/23	07/02/24	09/05/24	31/07/24	06/11/24	13/02/25	07/05/25	-	-	-	-	-	-	-

Upcoming sector events for Vanda Pharmaceuticals Inc.

02/07/2025	KALVISTA PHARMACEUTICALS, INC.: Q4 2025 Earnings Release (Projected)
09/07/2025	NURIX THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
22/07/2025	VIKING THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
23/07/2025	BIOCON LIMITED: Q1 2026 Earnings Release (Projected)
29/07/2025	CASSAVA SCIENCES, INC.: Q2 2025 Earnings Release (Projected)
29/07/2025	XENCOR, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	DYNE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KURA ONCOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	SANA BIOTECHNOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KEROS THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Vanda Pharmaceuticals Inc.

12/06/2025	SANBIO COMPANY LIMITED: Q1 2025 Earnings Release
09/06/2025 07:46	LUMOSA THERAPEUTICS CO., LTD.: May 2025 Sales and Revenue Release
05/06/2025 09:21	PHARMAESSENTIA CORPORATION: May 2025 Sales and Revenue Release
15/05/2025 13:00	TAYSHA GENE THERAPIES, INC.: Q1 2025 Earnings Release
14/05/2025	LIGACHEM BIOSCIENCES INC.: Q1 2025 Earnings Release
14/05/2025	PEPTRON, INC.: Q1 2025 Earnings Release
14/05/2025	OLIX PHARMACEUTICALS, INC: Q1 2025 Earnings Release
14/05/2025 21:05	ENLIVEN THERAPEUTICS, INC.: Q1 2025 Earnings Release
14/05/2025 12:00	SCHOLAR ROCK HOLDING CORPORATION: Q1 2025 Earnings Release
14/05/2025 02:00	BELITE BIO, INC: Q1 2025 Earnings Release